Cosmos Health Inc - SIC # 5122 - DRUGS, DRUG PROPRIETARIES, AND DRUGGISTS SUNDRIES

Ticker Exchange SIC # Website Latest Ticker
COSM Nasdaq 5122 http://www.cosmosholdingsinc.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cosmos Health Inc

Cosmos Health Inc.'s UK Subsidiary Decahedron Ltd. Named Pharmaceutical Wholesaler of the Month in the Latest Issue of Healthcare Matters - Mar 24th, 2023 2:35 pm
Cosmos Health Inc. Enters into a Definitive Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp. - Mar 17th, 2023 5:45 pm
Cosmos Health Enters into a Material Definitive Agreement with Cana Laboratories - Mar 7th, 2023 2:15 pm
Cosmos Health Expects to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp. - Mar 3rd, 2023 1:25 pm
Cosmos Health Extends its Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp. - Feb 15th, 2023 8:30 pm
Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests - Feb 7th, 2023 2:15 pm
Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM) - Feb 7th, 2023 1:30 pm
Cosmos Health Announces Application for Dual Listing on Upstream - Feb 2nd, 2023 6:50 pm
Cosmos Health Announces the Appointment of Nikos Bardakis, an Experienced Executive in the Pharmaceutical Industry, as Chief Operating Officer - Feb 1st, 2023 4:00 pm
Cosmos Health Retains Christian Levine Law Group to Further Monitor Trading Irregularities - Jan 26th, 2023 8:00 pm
Cosmos Health Announces Stock Buyback Program - Jan 24th, 2023 5:40 pm
Cosmos Health Extends and Updates its Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp - Jan 20th, 2023 6:40 pm
Cosmos Health Provides an Update on its Debt Balance and Proforma Interest Expense - Jan 17th, 2023 2:15 pm
Cosmos Health Extends and Updates its Agreement to Acquire Cana Laboratories, a European Pharmaceutical Company - Jan 10th, 2023 4:55 pm
Cosmos Health Regains Nasdaq Minimum Bid Price Compliance - Jan 5th, 2023 2:05 pm
Cosmos Health CEO Participated in the Last Fundraising of the Company - Dec 22nd, 2022 4:40 pm
Cosmos Health Inc. Announces Successful Closing of $32.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market - Dec 21st, 2022 9:10 pm
Cosmos Health Inc. Announces Pricing of $32.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market - Dec 19th, 2022 2:12 pm
Cosmos Holdings Inc. Changes its Name to Cosmos Health Inc. and Announces a 1-For-25 Reverse Stock Split - Dec 15th, 2022 12:45 pm
Cosmos Health Retains Shareholder Intelligence Services, LLC - Dec 9th, 2022 4:30 pm